| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1537-2995.2011.03362.X |
| P698 | PubMed publication ID | 21995641 |
| P50 | author | Frederik B. Clausen | Q42327851 |
| Morten Hanefeld Dziegiel | Q55100179 | ||
| Mette Christiansen | Q59163926 | ||
| P2093 | author name string | Rudi Steffensen | |
| Niels Grunnet | |||
| Christian Nielsen | |||
| Marianne Antonius Jakobsen | |||
| Steffen Jørgensen | |||
| Grethe Risum Krog | |||
| Klaus Rieneck | |||
| Ulrik Sprogøe | |||
| Keld Mikkelsen Homburg | |||
| Karina Jensen | |||
| Rikke Dyhrberg Madsen | |||
| P2860 | cites work | RHD positive haplotypes in D negative Europeans | Q24801894 |
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| RhD haemolytic disease of the fetus and the newborn | Q33901403 | ||
| Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008 | Q34306068 | ||
| Molecular genetics of RH and its clinical application | Q36431137 | ||
| Non-invasive antenatal RHD typing | Q36431820 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress | Q36735536 | ||
| Non-invasive prenatal diagnosis and determination of fetal Rh status | Q37077064 | ||
| Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects | Q37351817 | ||
| Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation | Q37390911 | ||
| The SAFE project: towards non-invasive prenatal diagnosis | Q37416234 | ||
| Noninvasive fetal blood grouping: present and future | Q39868111 | ||
| Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit. | Q44779251 | ||
| One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy | Q47683487 | ||
| Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis. | Q53597278 | ||
| Noninvasive fetal RhD genotyping from maternal blood. | Q54433693 | ||
| The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. | Q54520641 | ||
| Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. | Q54688617 | ||
| Workshop report on the extraction of foetal DNA from maternal plasma | Q56001878 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human pregnancy | Q11995 |
| pregnant person | Q104720811 | ||
| P304 | page(s) | 752-758 | |
| P577 | publication date | 2011-10-13 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis | |
| P478 | volume | 52 |
| Q38239704 | Anti-D prophylaxis: past, present and future |
| Q42393162 | Cell-free fetal DNA: the new tool in fetal medicine |
| Q38459998 | Circulating cell-free fetal DNA for the detection of RHD status and sex using reflex fetal identifiers |
| Q50489938 | Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies. |
| Q38586467 | Considerations of red blood cell molecular testing in transfusion medicine |
| Q38932336 | Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis |
| Q43448023 | Costs and benefits of non-invasive fetal RhD determination |
| Q51823244 | Determination of Fetal RHD Genotype Including the RHD Pseudogene in Maternal Plasma. |
| Q34132783 | Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study |
| Q53140707 | Epsilon globin gene expression in developing human fetal tissues. |
| Q64098977 | Evaluation of Automatic Blood Analyzer as Screening Method in Fetomaternal Hemorrhage |
| Q45984957 | Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups. |
| Q36837125 | Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran. |
| Q38200256 | Fetal blood grouping using cell free DNA - an improved service for RhD negative pregnant women |
| Q34286705 | From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges |
| Q50244580 | Guideline for blood grouping and red cell antibody testing in pregnancy |
| Q34472967 | Haemolytic disease of the fetus and newborn |
| Q40901636 | How to evaluate PCR assays for the detection of low-level DNA. |
| Q38178923 | Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care |
| Q46046965 | International reference reagents to standardise blood group genotyping: evaluation of candidate preparations in an international collaborative study |
| Q35507579 | Non-Invasive Prenatal RHD Genotyping Using Cell-Free Fetal DNA from Maternal Plasma: An Italian Experience |
| Q46118085 | Non-invasive prenatal diagnosis from the perspective of a low-resource country |
| Q90396106 | Non-invasive prenatal rhesus D genotyping using cell-free foetal DNA |
| Q51074981 | Non-invasive prenatal testing: ethics and policy considerations. |
| Q38549770 | Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA |
| Q48374688 | Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis |
| Q87466211 | Noninvasive fetal RhD genotyping |
| Q48240788 | Noninvasive prenatal testing: the paradigm is shifting rapidly |
| Q35034936 | Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD |
| Q102331644 | Prenatal RHD genotyping in Croatia: preliminary results |
| Q54088983 | Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis. |
| Q35977052 | Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus |
| Q51694638 | Quantitative fetomaternal hemorrhage assessment with the use of five laboratory tests. |
| Q34312211 | Recent advances in the prenatal interrogation of the human fetal genome |
| Q36794228 | Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma |
| Q27687533 | Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice |
| Q46227317 | Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark. |
| Q34853996 | Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of women |
| Q37397918 | Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands |
| Q43605070 | Should cell-free DNA testing be used to target antenatal rhesus immune globulin administration? |
| Q38656110 | Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland |
| Q34936608 | Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program |
| Q55007705 | The Most Favourable Procedure for the Isolation of Cell-Free DNA from the Plasma of Iso-Immunized RHD-Negative Pregnant Women. |
| Q30250029 | The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. |
| Q43476137 | Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS. |
| Q91872228 | Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization |
| Q38083742 | Variants of RhD--current testing and clinical consequences |
| Q48339604 | Vox Sanguinis International Forum on application of fetal blood grouping. |
| Q48339570 | Vox Sanguinis International Forum on application of fetal blood grouping: summary. |
| Q37333449 | Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice? |
Search more.